Condition

EGFR Negative Non-Small Cell Lung Cancer

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions2

Lead sponsors shown1

Clinical trials

1 shown

Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLCNCT03611738 · 2019-02-01

ACTIVE_NOT_RECRUITING

Common interventions

CeritinibDRUG1DocetaxelDRUG1

Leading sponsors

H. Lee Moffitt Cancer Center and Research Institute1

Trial status mix

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.